Current FDA Approval Process

• Safety: Pre-clinical testing of several dosages over relevant time periods on at least two species

• Carefully planned clinical trials with signed informed consent and annual reports

  • Phase 1 clinical trials: Small doses on healthy volunteers: Pharmacokinetics and side effects
  • Phase 2: Small sample of hospital patients
  • Phase 3: Broader clinical trials on patients

Previous slide

Next slide

Back to first slide

View graphic version